SanBio Co (TSE:4592) Total Equity: 円13,604.67 Mil (As of Jan. 2026)


TSE:4592 SanBio Co Ltd TSE:4592
22 GF Score
Price 円997.00
! 1 Warning Sign
View Full Analysis

What is SanBio Co Total Equity?

SanBio Co TSE:4592 +4.95% 22 Total Equity is 円13,604.67 Mil as of Jan. 2026. GuruFocus rates TSE:4592 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

SanBio Co's total equity for the quarter that ended in Jan. 2026 was 円13,604.67 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SanBio Co Total Equity Historical Data

* Premium members only.

The historical data trend for SanBio Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SanBio Co Total Equity Chart

SanBio Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,035.14 4,428.91 2,792.40 1,762.92 13,604.67

SanBio Co Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,895.02 1,294.17 492.19 13,604.67 12,677.95
TSE:4592
22GF Score
SanBio Co Ltd TSE:4592
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SanBio Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SanBio Co's Total Equity for the fiscal year that ended in Jan. 2026 is calculated as

Total Equity=Total Assets(Q: Jan. 2026 )-Total Liabilities(Q: Jan. 2026 )
=15621.539-2016.872
=13,604.67

SanBio Co's Total Equity for the quarter that ended in Jan. 2026 is calculated as

Total Equity=Total Assets(Q: Jan. 2026 )-Total Liabilities(Q: Jan. 2026 )
=15621.539-2016.872
=13,604.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円13,604.67 Mil mean?
SanBio Co (TSE:4592) has a Total Equity of 円13,604.67 Mil as of Jan. 2026. The total amount of equity as record on a company's balance sheet. View historical data for SanBio Co and its competitors.
Is SanBio Co's Total Equity too high?
SanBio Co's current Total Equity is 円13,604.67 Mil. Overall, SanBio Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Total Equity compare to VRTX and REGN?
SanBio Co's Total Equity of 円13,604.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for SanBio Co and its competitors. SanBio Co's current Total Equity is 円13,604.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (TSE:4592) has a current Total Equity of 円13,604.67 Mil. The current Total Equity is 円13,604.67 Mil. SanBio Co's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For SanBio Co (TSE:4592), the current Total Equity is 円13,604.67 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SanBio Co Business Description

Address 8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
22GF Score

Get the complete analysis for TSE:4592

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円997.00
Price